Xponance, Inc. Haemonetics Corp Transaction History

Xponance, Inc.

$10.1 Billion
Q1 2025

A detailed history of Xponance, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Xponance, Inc. holds 7,232 shares of HAE stock, worth $543,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,232

Previous 7,246 0.19%

Holding current value

$543,846

Previous $565,000 18.76%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$59.34 - $80.05 $830 - $1,120	-14 Reduced 0.19%	7,232 $459,000
Q4 2024 Feb 10, 2025	BUY	$71.16 - $93.38 $28,748 - $37,725	404 Added 5.9%	7,246 $565,000
Q3 2024 Nov 12, 2024	BUY	$72.45 - $91.58 $2,318 - $2,930	32 Added 0.47%	6,842 $549,000
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $36,070 - $43,232	-444 Reduced 6.12%	6,810 $563,000
Q1 2024 May 13, 2024	SELL	$71.24 - $85.35 $7,337 - $8,791	-103 Reduced 1.4%	7,254 $619,000
Q4 2023 Jan 31, 2024	BUY	$80.59 - $92.61 $7,494 - $8,612	93 Added 1.28%	7,357 $629,000
Q3 2023 Oct 23, 2023	SELL	$82.56 - $93.49 $9,659 - $10,938	-117 Reduced 1.59%	7,264 $650,000
Q2 2023 Jul 13, 2023	SELL	$80.84 - $89.45 $37,833 - $41,862	-468 Reduced 5.96%	7,381 $628,000
Q1 2023 Apr 17, 2023	SELL	$72.75 - $90.6 $2,473 - $3,080	-34 Reduced 0.43%	7,849 $649,000
Q4 2022 Jan 23, 2023	SELL	$73.85 - $86.14 $5,612 - $6,546	-76 Reduced 0.95%	7,883 $0
Q3 2022 Oct 24, 2022	BUY	$63.3 - $78.66 $633 - $786	10 Added 0.13%	7,959 $589,000
Q2 2022 Aug 02, 2022	BUY	$49.27 - $66.08 $25,275 - $33,899	513 Added 6.9%	7,949 $518,000
Q1 2022 Apr 20, 2022	SELL	$43.77 - $63.22 $2,976 - $4,298	-68 Reduced 0.91%	7,436 $470,000
Q4 2021 Jan 31, 2022	SELL	$49.55 - $74.59 $4,063 - $6,116	-82 Reduced 1.08%	7,504 $398,000
Q3 2021 Nov 05, 2021	SELL	$57.6 - $70.59 $23,961 - $29,365	-416 Reduced 5.2%	7,586 $535,000
Q2 2021 Aug 12, 2021	SELL	$51.81 - $118.56 $120,043 - $274,703	-2,317 Reduced 22.45%	8,002 $533,000
Q1 2021 May 10, 2021	BUY	$111.01 - $139.48 $22,646 - $28,453	204 Added 2.02%	10,319 $1.15 Million
Q4 2020 Feb 11, 2021	SELL	$88.75 - $119.95 $532 - $719	-6 Reduced 0.06%	10,115 $1.2 Million
Q3 2020 Oct 26, 2020	BUY	$75.65 - $93.58 $58,931 - $72,898	779 Added 8.34%	10,121 $883,000
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $793,696 - $1.11 Million	9,342 New	9,342 $837,000

Others Institutions Holding HAE

# of Institutions

352

Shares Held

53.2M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account